scholarly article | Q13442814 |
P50 | author | Patrizia Agostinis | Q30111808 |
Sofie Claerhout | Q59028913 | ||
P2093 | author name string | Rita De Vos | |
Lien Verschooten | |||
Marjan Garmyn | |||
Charlotte Proby | |||
Sofie Van Kelst | |||
P2860 | cites work | LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 |
How to interpret LC3 immunoblotting | Q29614175 | ||
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3 | Q29614176 | ||
Casein kinase Iepsilon down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells | Q40353722 | ||
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autophagy | Q288322 |
apoptotic process | Q14599311 | ||
P1104 | number of pages | 14 | |
P304 | page(s) | 2790-2803 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma | |
P478 | volume | 127 |
Q61811185 | A Systematic Review of miR-29 in Cancer |
Q92128642 | A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing |
Q34373138 | A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy. |
Q34321373 | Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells. |
Q39402233 | Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells. |
Q47693087 | Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy |
Q26865957 | Autophagy and cancer |
Q35591562 | Autophagy as a therapeutic target in cancer. |
Q38034270 | Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity |
Q39070884 | Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells |
Q34461140 | Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells |
Q34089685 | Cellular Responses to Cisplatin‐Induced DNA Damage |
Q30513775 | Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy |
Q38045433 | Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. |
Q41516517 | DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy |
Q34475613 | Deciphering squamous cell carcinoma using multidimensional genomic approaches |
Q55366569 | Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients. |
Q39008754 | Discovery of 2'-hydroxychalcones as autophagy inducer in A549 lung cancer cells |
Q34677497 | Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells |
Q54368748 | Epithelial-mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation. |
Q38868212 | Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance |
Q54120670 | Expression profiling analysis of autophagy-related genes in perineural invasion of cutaneous squamous cell carcinoma. |
Q91756033 | Gefitinib-mediated apoptosis is enhanced via inhibition of autophagy by chloroquine diphosphate in cutaneous squamous cell carcinoma cells |
Q41926329 | Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy. |
Q34552915 | MODULATION OF AUTOPHAGY AND ITS POTENTIAL FOR CANCER THERAPY. |
Q38068799 | MicroRNA: a third dimension in autophagy |
Q91603927 | Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms |
Q39392030 | Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential |
Q46614504 | Pattern of sensitivity of progressive cutaneous squamous cell carcinoma cells to UVB and oxidative stress-induced cell death |
Q39392171 | Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation |
Q34231282 | Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure |
Q33579758 | Protective autophagy antagonizes oxaliplatin-induced apoptosis in gastric cancer cells |
Q38696036 | Radiation-induced autophagy: mechanisms and consequences. |
Q37407621 | Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid. |
Q38209432 | Role of autophagy in head and neck cancer and therapeutic resistance. |
Q52716859 | Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis. |
Q34774451 | Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells. |
Q37876468 | Survivin in skin pathologies |
Q39289967 | The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. |
Q90749105 | The importance of epithelial-mesenchymal transition and autophagy in cancer drug resistance |
Q40051484 | Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer |
Q39339490 | Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells |
Q36495731 | Topical curcumin-based cream is equivalent to dietary curcumin in a skin cancer model |
Q92783226 | Wnt Signaling Pathways in Keratinocyte Carcinomas |